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Abstract: Mistletoe Extracts (ME) are of growing interest to pharmacological research because of their apoptosis-
inducing/cytostatic and immunomodulatory effects. The standardization of the three different groups of Mistletoe Isolectins 
(ML-I, II and III) is often rendered more difﬁ  cult since the primary structures are nearly identical. Their classiﬁ  cation is 
based on their Galactose- and N-acetyl-D-galactosamine (GalNAc)-speciﬁ  city which was measured by various inhibitory 
assays. The aim of the present study was to improve the characterization of the direct binding activity of the isolectins from 
ME to immobilized lactose, GalNAc and to the oligosaccharide asialofetuin. After careful ultraﬁ  ltration of fresh ME, afﬁ  n-
ity chromatography was carried out using lactose- agarose, GalNAc—agarose and asialofetuin—afﬁ  gel 15 columns. MLs 
were further puriﬁ  ed by Sephadex G-100 or by cation exchange chromatography which was adapted to a Fast Protein Liq-
uid Chromatography (FPLC) system. Proteins from both fresh plants and commercial ME were able to bind immobilized 
lactose to a considerable extent. The majority of this lectin has a B-chain with a Molecular Weight (MW) of 34kD and an 
A-chain with a MW of 29 kD (ML-I). Only a minor part of the lactose-binding proteins has a lower MW, namely 32kD and 
27kD (MLII). However, neither MLs which were eluted from lactose columns, nor the proteins from fresh plant or ME 
showed a direct binding to the immobilized GalNAc. In spite of this deﬁ  ciency, GalNAc was able to induce a considerable 
(25% and 32%) inhibitory effect on their binding to immobilized asialofetuin indicating a discrepancy between the lectin 
binding and inhibiting effects of GalNAC. Consequently, for an improved standardization of ME more speciﬁ  c sugar mol-
ecules are necessary.
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Introduction
In the standardization of commercial mistletoe extracts, the correct determination of mistletoe lectins 
plays an important role. However, plant mistletoe lectins exhibit a heterogeneity which most likely 
results from the posttranslational processing of Mistletoe Lectins (ML)-I to the isoforms ML-II and 
ML-III [Eck, 1999] since only a small difference was found in their primary structure. The antigenic 
analysis of B- subunit in ML-I and ML-III showed one epitope 
25RDDDFRDGNQ
34 in ML-I that is 
absent in B chain of ML-III and this difference can be related to a little gene polymorphism [Pevzner, 
2004]. Mistletoe extract preparations vary with regard to the content of ML-isoforms, which also may 
depend on the method of isolation or on various degradation effects. Growing evidence suggest that 
immunomodulatory efﬁ  cacy of mistletoe extracts (ME) is dose-dependent with a bell-shaped dose-curve 
and correlates with the lectin-sugar interactions on the membrane of various immune cells [Hajto, 1989a; 
Hajto, 1989b]. However, it has been criticized that mainly ML-I was taken into consideration instead 
of ML-II or ML-III for immunological research and standardization of ME [Jäggy, 1995]. The chemical 
deﬁ  nition of ML-II and III is based on the lower molecular weights, the small differences in primary 
structures and on the observation that N-acetyl-D-galactosamine (GalNAc) exhibits a more marked 
inhibition on ML-II or ML-III-induced hemagglutination or cytostatic activity than the galactose-speciﬁ  c 
ML-I. However, few data are available concerning binding capacity of ML-II and ML-III to immobilized 
GalNAc. In the present study, the aim was to minimize degradation effects during the separation. There-
fore, mistletoe lectins were carefully isolated from fresh plants and from commercial mistletoe extracts 
by ultraﬁ  ltration and using afﬁ  nity chromatography. The direct binding capacity of MLs to lactose and 
to GalNAc was compared in the same system. Surprisingly, no direct binding to immobilized GalNAc 
was detected. Only immobilized lactose was able to bind MLs from our specially prepared extract. 44
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These unexpected ﬁ  ndings can be interesting for 
the further research of MLs which requires new 
perspectives to find appropriate ligands with 
considerably higher afﬁ  nity for MLs, such as CD75 
gangliosides as described several years ago 
[Müthing, 2002]. Since CD75 oligosaccharides can 
exist on a great number of effector cells of innate 
immune system [Kawashima, 2003], MLs may be 
important candidates for an immunotherapy with 
targeting strategy.
Material and Methods
Material
Mistletoe plants freshly picked from apple trees 
during the winter months when the lectin content 
of leaves and stems is high [Urech, 2001] were 
kindly provided by Dr. Urech (Society for Cancer 
Research, Switzerland). Commercial Mistletoe 
Extract (M spec 200 mg 4125 SF 0404) was kindly 
provided by Dr. M.Werner (Society for Cancer 
Research, Switzerland).
Ultraﬁ  ltration
To avoid possible denaturation by ammonium sulfate 
precipitation during the isolation of MLs, a Sartocon 
Mini Crossﬂ  ow ultraﬁ  ltration system was used which 
allows a gentle preparation using low pressure and 
temperature as well as a short procedure. After 
extraction of fresh plants (leaves and two terminal 
stems) in phosphate buffered saline (PBS) solution 
at 4 °C overnight. To remove the solid particles the 
suspension was ﬁ  ltered and centrifuged at 15' 000 g 
for 7 min and then the pellet was discarded. Using a 
Watson Marlow pump, the supernatant was ultraﬁ  l-
tered in a Sartocon Mini Crossﬂ  ow system (Sartorius 
GmbH, D-Göttingen) through a cellulose acetate 
ﬁ  lter (Typ 303 145 49 01E) with 20' 000 NMGT. 
Based on the instructions of the manufacturers, the 
slow speed of the pump (43 rpm) guaranteed a low 
pressure (<0.2 bar) during the procedure. After 
circulation through the ﬁ  lter for one hour a protein 
concentrate was obtained with a MW >20 kD.
Afﬁ  nity chromatography
Alfa-lactose agarose was purchased from Sigma 
Aldrich GmbH (Switzerland) and the column 
(0.8 × 11 cm) was pre-equilibrated with PBS. The 
ﬂ  ow rate was 15 ml/hr. The elution was carried out 
with 0.2 M lactose and the eluted fractions were 
checked using a Specord M40 spectrophotometer 
(Zeiss, Jena, Germany) at 280 nm. Each fraction 
contained 1.5 ml elute allowing a kinetic judgment 
of the elution process. The eluate was dialyzed 
against PBS and/or bidistilled water and concen-
trated to 1 mg/ml protein (Lowry method) using 
Microcon YM-30 tubes (Millipore, Switzerland). 
GalNAc—agarose column (SigmaAldrich GmbH; 
Switzerland) was prepared and used in a similar 
manner as described for lactose—agarose. The 
elution was carried out with 0.2M GalNAc and 
1.5 ml fractions were examined with a spectropho-
tometer against 0.2M GalNAc. An ultraﬁ  ltrate of 
ME from fresh plants was also passed through an 
affinity column of asialofetuin (Sigma Aldrich 
GmbH, Switzerland) bound to Afﬁ  gel 15 (Bio-Rad 
Laboratories AG, CH-Reinach) according to the 
method described by the manufacturer. This column 
was ﬁ  rst equilibrated with equilibration buffer (0.1M 
Tris HCl, 0.5M NaCl, pH7), before passing the ME 
ultraﬁ  ltrate through at a ﬂ  ow rate of 4ml/min. The 
column was washed with the equilibration buffer 
until there was no detectable absorption at 280 nm 
in the eluate. Then the adsorbed proteins (MLs) were 
eluted with 0.1M glycine buffer (pH 3). The pH of 
the fractions was immediately increased neutralized 
with 1M Tris-HCl buffer (pH 7). Sephadex G-100 
was purchased from Sigma Aldrich GmbH (Swit-
zerland) and the column (0.8 × 60 cm) was pre-
equilibrated with TRIS buffer (pH 7.5) containing 
0.2M NaCl before washing with PBS. The eluate 
from the lactose agarose column was added to this 
Sephadex G-100 column. The colunn was then 
eluted at a ﬂ  ow rate of 10 ml/hr and collected in 
volumes of 0.5 ml. The afﬁ  nity chromatography 
procedures were carried out at 4 °C.
Fast protein liquid chromatography 
(FPLC) separation of eluted MLs 
using cation exchange 
chromatography
The eluate from the afﬁ  gel-asialofetuin column 
was dialysed against 15 mM citrate buffer (pH 4.2), 
then concentrated to 2 mg/ml using Microcon YM-
30 tubes (Millipore, Switzerland) before applying 
to a cation exchange chromatography column 
(Mono S 5/50 GL; Amersham Bioscience, 
Switzerland). The column was adapted to a FPLC 
system and equilibrated with citrate buffer (pH 
4.2). MLs were eluted with a linear NaCl gradient 
from 0.2 to 0.5M in citrate buffer.45
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Electrophoresis
Polyacrylamide gel electrophoresis was performed 
according to conventional methods [Laemmli, 1970; 
Ziska, 1993] using 10% polyacrylamide with sodium 
dodecyl sulfate (SDS) in 1.5M Tris buffer (pH 8.8). 
The running buffer was Tris/Glycine (pH 8.3) and 
SDS. The gels were stained with comassie blue. 
Mercaptoethanol was used as reducing agent.
Enzyme linked lectin assay (ELLA)
The binding capacity of isolated mistletoe lectins 
from plants and extracts to asialofetuin was carried 
out with an optimized ELLA technique as described 
previously [Hajto, 1989a]. Brieﬂ  y, the method is 
based on binding of lectin to an immobilized oligo-
saccharide ligand (asialofetuin) and subsequent 
binding of speciﬁ  c (polyclonal) antibody to the 
bound lectin. The speciﬁ  c binding of rabbit anti-
bodies was quantitatively assessed using goat 
anti-rabbit peroxidase and the subsequent genera-
tion of a colored product from the substrate phenyl-
endiamine hydrochloride. The measurements were 
carried out in an enzyme-linked immunosorbent 
assay plate reader at 492 nm. After its isolation 
from fresh mistletoe plant, the standard galacto-
side-binding mistletoe lectin was previously 
lyophilized. The solubility of this standard material 
was improved by addition of non-speciﬁ  c sugars 
and its amount was determined gravimetrically.
Results
Binding of mistletoe protein 
concentrate to immobilized lactose 
and GalNAc
The binding of fresh plant MLs to immobilized galac-
tose or GalNAc was ﬁ  rst examined. The ultraﬁ  ltration 
of fresh plant aqueous ME followed by afﬁ  nity chro-
matography allowed a gentle isolation of the protein 
(ML) concentrate. To investigate the binding of this 
concentrated protein to immobilized sugars, lactose-
agarose and GalNAc-agarose afﬁ  nity chromatography 
columns were run in parallel under the same condi-
tions. Figure 1 represents the UV absorbtion of the 
eluted fractions measured spectrophotometerically. 
As demonstrated in Figure 1-A, the addition of 0.2M 
lactose to lactose-agarose column caused a prompt 
elution of abundant galactoside-binding mistletoe 
lectin. However, no GalNAc—speciﬁ  c lectin was 
eluted on the other column (Fig. 1-B).
Among the carefully isolated plant proteins, no 
lectin which bound directly to immobilized 
GalNAc could be detected. In addition, lectins 
eluted from lactose-agarose on GalNAc—agarose 
column were also tested and no direct binding to 
this sugar was detected (data not shown).
Comparison of the binding of mistle-
toe proteins from commercial extracts 
to immobilized lactose and GalNAc
As previously shown [Jäggy, 1995], commercial 
ME has been shown to contain detectable amount 
of ML-II and ML-III and their agglutination-
inducing and cytotoxic effects (ML-III>MLII) 
with GalNAc were more strongly inhibited than 
with lactose or galactose [Jäggy, 1995; Franz, 
1981; Ziska, 1993; Frantz, 2000]. Therefore, the 
direct binding of ME proteins to immobilized 
sugars was also tested using afﬁ  nity chromatog-
raphy. As shown in Figure 1-C, after afﬁ  nity 
chromatography on the lactose-agarose column, 
the elution with lactose resulted in a prompt 
occurrence of galactoside-binding mistletoe 
lectins. However, as with fresh plant extract on a 
GalNAc—agarose column, no GalNAc—binding 
lectin was eluted (Fig. 1-D). The binding of ML-
III may require a different spacer for the binding 
of terminal GalNAc to ML.
Characterization of galactose-binding 
mistletoe proteins by electrophoresis 
and by afﬁ  nity chromatography 
on Sephadex G-100
As shown in Figure 2-A, the majority of galactose-
binding mistletoe lectins which were isolated by 
affinity chromatography consisted of a 34kD 
B-chain and an A-chain of 29kD. Although MLs 
were not quantitatively isolated, small amounts of 
another molecule with 32kD and 27kD chains appear 
to be present, which may correspond to MLII/III. 
MLs from mistletoe extract isolated by afﬁ  nity 
chromatography on lactose- agarose column show 
a similar pattern in electrophoresis (Fig. 2-b).
For more exact examination of this heteroge-
neity, MLs isolated from fresh plants using afﬁ  nity 
chromatography on sephadex G-100 were also 
tested. These investigations are not conclusive, but 
the ﬁ  rst kinetic measurements of 0.5 ml eluted 
fractions by spectrophotometer also point to only 
a slight heterogeneity in the molecular weights of 46
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these lectins (data are not shown). Further 
investigations are in progress.
Inhibitory effect of lactose and 
GalNAc on the direct binding of MLs 
isolated from fresh plants and from 
commercial mistletoe extract to 
immobilized asialofetuin using ELLA
Since immobilized GalNAc was not able to bind 
proteins from fresh mistletoe plants or commercial 
extract, the inhibitory effect of this sugar on the 
direct binding to immobilized asialofetuin was also 
investigated using the ELLA method. As shown in 
Figure 3-A, MLs isolated from fresh plants by 
affinity chromatography on a lactose-agarose 
column in the presence of 0.1M lactose revealed 
89% decrease in the binding of MLs to asialofetuin. 
Surprisingly, GalNAc was also able to induce a 25% 
inhibition (Fig. 3-A) in spite of the fact that no direct 
binding of these MLs to GalNAc was detected using 
afﬁ  nity chromatography. Similarly different inhibi-
tions by lactose and GalNAc (72% and 32% 
decreases, respectively) were observed with 
commercial mistletoe extracts (Fig. 3-B).
Separation of mistletoe lectins 
by cation exchange chromatography 
adapted to FPLC
Since MLs are positively charged because of their 
NH3
+ cations, cation exchange chromatography 
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Figure 1. Kinetic representation of lectin content in 1.5 ml eluted fractions measured spectro-photometrically after afﬁ  nity chromatography 
of fresh mistletoe plant (leaf and stem) ultraﬁ  ltrate on lactose-agarose column (A) and on GalNAc-agarose column (B) or after the same 
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Figure 2. Polyacrylamide gel electrophoresis of lactose-binding 
lectins isolated from fresh mistletoe plants (a) and from commercial 
mistletoe extract, Iscador M-spec (b) after a treatment with reducing 
agent. The molecular weight of lectin bands from above down wards 
are the following: 34kD, 32kD (corresponding to B chains of ML-I 
and ML-II/III, respectively) as well as 29kD and 27kD (corresponding 
to A chains of ML-I and ML-II/III, respectively). 
a                b
adapted to FPLC was selected for their further 
separation. As shown in Figure 5, using linear 
gradients from 0.1M to 0.5M NaCl, this method 
also resulted in a small heterogeneity of fresh plant 
MLs eluted from the Afﬁ  gel-Asialofetuin column. 
The rather small ﬁ  rst peak at 0.325 NaCl concen-
tration may represent MLII and III followed by a 
larger second peak between 0.35M and 0.375M 
NaCl that could correspond to ML-I. However, the 
Figure 3. Inhibitory effect of lactose and GalNAc on the binding of MLs to immobilized asialofetuin using ELLA method. Lactose 
binding lectin from fresh plant (corresponding to 650 ng lyophilized standard lectin) was investigated by ELLA in presence of 0.1M 
lactose and 0.1M GalNAc (A). Similar investigations were carried out with Iscador
R Qu-special the lectin content of which corresponded 
to 335 ng standard (B).
further separation of MLs was not successful and 
the electrophoresis also did not support this 
hypothesis since the fractions originated from the 
large second peak of FPLC were also not homo-
geneous (Fig. 4).
Discussion
Recent investigations with mistletoe lectins 
from fresh plants and extracts suggest that new 
preparation techniques may lead to novel 
chemical entities which are not identical with 
the previous results [Franz, 1981; Ziska, 1993; 
Frantz, 2000]. On the base of earlier procedures 
with affinity chromatography, three important 
groups of isolectins were repeatedly identified: 
D-galactose-specific ML-I, D-galactose and 
GalNAc-specific ML-II as well as GalNAc—
specific ML-III [Franz, 1981; Ziska, 1993; 
Frantz, 2000]. Further differentiation of these 
MLs was based on their different MWs and on 
the differences in the sugar-induced inhibition 
of their cytotoxic or agglutinin activities. In 
contrast to these data, several investigators 
established only two types of MLs (galactose—
and GalNAc-specific ML-I and II) in various 
mistletoe extracts [Samtleben, 2001]. Conse-
quently, in the present experiments, the lack of 
the binding of proteins from mistletoe plant and 48
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Separation of MLs by cation exchange chromatography 
adapted to FPLC
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Figure 4. Separation of MLs by cation exchange chromatography adapted to FPLC. Using linear gradients from 0.1M until 0.5M NaCl, the 
fractions of MLs were eluated from Mono S 5/5O GL column. The small ﬁ  rst peak at 0.325M NaCl concentration may represent MLII / III and 
the second peak between 0.35 and 0.375M NaCl level could correspond to ML-I. 
extract to immobilized GalNAc is unexpected. 
For isolation of MLII and III various methods 
were used. Previously, a protein concentrate 
from ME was usually obtained using ammonium 
sulfate precipitation followed by isolation of 
MLs using acid-treated Sepharose or Affigel-
15-asialofetuin column for affinity chromatog-
raphy. MLII/III were separated by various 
methods employing immunoglobulin—sepha-
rose and sepharose-N (6-aminohexanoyl)-D-
galactosamine [Jäggy, 1995] or sephadex G-100 
[Ribereau, 1997] or cation exchange chroma-
tography columns [Frantz, 2000; Eifler, 1993]. 
In the present experiments, MLs were carefully 
isolated by ultrafiltration and by affinity chro-
matography using various agarose—sugar 
columns keeping the pH, ionic strength and 
temperature within a constant optimal range 
during the procedure. However, from the present 
results it is not possible to make a definitive 
conclusion and further comparative investiga-
tions are necessary to clarify the reasons for the 
discrepancy between the previous [Ribereau, 
1997; Frantz, 2000; Urech, 2006] and present 
results concerning the binding capacity of 
ML-III to GalNAc. The binding of ML-III to 
GalNAc-agarose column may require a different 
spacer which could better help the binding of 
terminal GalNAc to ML. Consequently, further 
comparative investigations are necessary. The 
most probable hypothesis for this discrepancy 
may be connected with the discovery [Müthing, 
2002] that galactose, lactose and other mono- or 
disaccharides exhibit only a weak affinity to 
MLs if they were compared with CD75 receptors 
which are terminally α2-6-sialylated ganglio-
sides.
The differences in the molecular mass and sugar 
binding of the two or three species were also 
thought to be a result of the degree of glycosylation 
[Zimmermann, 1996]. For example, recombinant 
ML is not glycosylated and using competitive 
ELLA, GalNAc was found to have a stronger 
inhibitory effect on the binding of recombinant ML 
to immobilized asialofetuin than that of galactose, 
indicating a potential role for glycosylation in the 
sugar-induced inhibitory actions [Zinke, 1996]. 
The complete amino acid sequence of the A- and 
B-chains of ML-I has been determined [Soler, 
1996; Soler, 1998]. The A chain contains 254 49
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amino acid residues and using matrix-assisted laser 
desorption ionization mass spectrometry (MALDI-
MS), the existence of a potential N-glycosylation 
site was conﬁ  rmed [Soler, 1996]. The sequence 
Asn
112-Gly
113-Ser
114 could be identiﬁ  ed as a glyco-
sylation pattern. The bound carbohydrate moiety 
showed a MW of 1173 Da. The B-chain is 
composed of 264 amino acid residues and three 
potential N-glycosylation sites were conﬁ  rmed by 
MALDI-MS analysis [Soler, 1998]. These are 
Asn
61-Gly
62-Ser
63, Asn
96-Gly
97-Thr
98 and Asn
136-
Asp
137-Thr
138, respectively. The three sugar chains 
are covalently bound to the protein part of the B-
chain and show a MW of 3900 Da. Isolation 
methods can induce alterations in the glycosylation 
pattern of MLs [Zimmermann, 1996]. It was also 
concluded that glycosylation of MLs mainly inﬂ  u-
ences stability, conformational variants, non-
specific binding and solubility [Pfüller, 2001; 
Lutter, 2001].
Many years ago it was established by 2-D gel 
electrophoresis that there are at least 40 isolectins 
of MLs [Samtleben, 2001]. For the chemical 
standardization of the clinically applied ME 
preparations, the exact determination of isolectin 
patterns is not possible. The amino acid analysis 
revealed 17 conservative substitutions along the 
amino acid sequence of the A-chain. The most 
noteworthy substitution may be the replacement 
of Asn
112 → Thr
112, which presumably eliminates 
the glycosylation signal in the amino acid 
sequence (Asn
112-Gly
113-Ser
114 → Thr
112- Gly
113-
Ser
114). These results provide evidence that the 
A-chain of ML-I has at least two isoforms, one 
glycosylated and one non-glycosylated [Soler, 
1996] which may also correspond to our FPLC 
result. A small heterogeneity in the peak of ML-I 
was detected. Analyzed sequence data of B-chain 
also show 12 conservative substitutions, most of 
them located in the C-terminal region of the 
protein. These findings demonstrate that the 
B-chain, like the A-chain occurs in several 
isoforms, supporting further evidence for the 
previously reported existence of different isolec-
tins of ML-I [Soler, 1998].
Because of the heterogeneity of ML isoforms, 
an exact immunological standardization of 
commercial ME is not easy. For example, different 
laboratories using the same methods (cation 
exchange chromatography adapted to FPLC) 
found that the ML peaked at dissimilar NaCl 
concentrations even if the same linear gradients 
were applied [Frantz, 2000; Eiﬂ  er, 1993]. Previous 
studies with ME revealed that the immunomodu-
latory effects and the sugar-binding activity of an 
extract have a close relationship [Hajtò, 1990]. 
Therefore it would be advisable to employ a 
standard procedure for the exact and reproducible 
determination of sugar-binding potency of ME 
using chemically well-deﬁ  ned, stable and reliable 
lectin standards.
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